Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynecological Surgical Sites
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Mohamed abdel ghfar
- Phone Number: +20 10 61624335
- Email: mohamedeleboany@gmail.com
Study Locations
-
-
-
Minya, Egypt
- Recruiting
- Minia advanced laparoscopy unit
-
Contact:
- Mohamed abdelghfar, Lecturer
- Phone Number: +20 10 61624335
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of a surgical site infection (SSI) following an obstetric or gynecological surgical procedure (e.g., Cesarean section, hysterectomy, myomectomy, salpingo-oophorectomy).
- Wound classification as superficial incisional SSI, deep incisional SSI, or organ/space SSI (if accessible for VSD application).
- Willingness and ability to provide informed consent.
- Wound requiring secondary intention healing or delayed primary closure after debridement
Exclusion Criteria:
- Patients with necrotic tissue.
- Presence of exposed blood vessels, organs, or anastomotic sites where VSD is contraindicated.
- Untreated coagulopathy or active bleeding diathesis.
- Allergy to VSD components or dressing materials.
- Patients with significant immunosuppression (e.g., uncontrolled HIV, organ transplant recipients on high-dose immunosuppressants).
- Patients with malignant wounds.
- Patients who decline participation.
- Patients requiring immediate primary wound closure without debridement.
- Patients with a known history of severe psychiatric illness affecting compliance.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Conventional Wound Care Group
|
o Wounds will be managed with daily or twice-daily dressing changes using saline-moistened gauze, antiseptic solutions, and sterile dry dressings, as per standard hospital protocols for infected wounds
|
|
Experimental: Vacuum Sealing Drainage (VSD) Group
|
After initial debridement, a VSD system will be applied to the wound bed.
The wound will be sealed with an adhesive drape, and connected to a negative pressure unit.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to complete wound healing
Time Frame: weekly follow up for one month after procedure
|
Defined as complete epithelialization of the wound, measured in days
|
weekly follow up for one month after procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1705-9-25
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.